PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.21M | 3.69M | 3.42M | 4.31M | 4.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.88M | 19.02M | 19.24M | 22.52M | 22.88M |
| Operating Income | -18.88M | -19.02M | -19.24M | -22.52M | -22.88M |
| Income Before Tax | -18.08M | -18.04M | -18.01M | -21.07M | -21.21M |
| Income Tax Expenses | 3.00K | -- | 26.00K | -6.00K | 5.00K |
| Earnings from Continuing Operations | -18.09M | -18.04M | -18.04M | -21.06M | -21.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.09M | -18.04M | -18.04M | -21.06M | -21.21M |
| EBIT | -18.88M | -19.02M | -19.24M | -22.52M | -22.88M |
| EBITDA | -18.86M | -18.99M | -19.21M | -22.49M | -22.85M |
| EPS Basic | -0.34 | -0.34 | -0.34 | -0.40 | -0.41 |
| Normalized Basic EPS | -0.21 | -0.21 | -0.21 | -0.25 | -0.25 |
| EPS Diluted | -0.34 | -0.34 | -0.34 | -0.40 | -0.41 |
| Normalized Diluted EPS | -0.21 | -0.21 | -0.21 | -0.25 | -0.25 |
| Average Basic Shares Outstanding | 53.39M | 53.33M | 53.20M | 52.99M | 52.01M |
| Average Diluted Shares Outstanding | 53.39M | 53.33M | 53.20M | 52.99M | 52.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |